Menu
Back to User profile » Professor Kanji Takahashi
Papers published by Professor Kanji Takahashi:
Patient Preferences for Anti-Vascular Endothelial Growth Factor Treatment for Wet Age-Related Macular Degeneration in Japan: A Discrete Choice Experiment
Joko T, Nagai Y, Mori R, Tanaka K, Oshima Y, Hikichi Y, Komori T, Carrasco J, Maculaitis MC, Will O, Beusterien K, Takahashi K
Patient Preference and Adherence 2020, 14:553-567
Published Date: 12 March 2020
Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
Koike N, Otsuji T, Tsumura A, Miki K, Sakai Y, Nishimura T, Takahashi K
Clinical Ophthalmology 2019, 13:1247-1251
Published Date: 15 July 2019
Efficacy and safety of ranibizumab monotherapy versus ranibizumab in combination with verteporfin photodynamic therapy in patients with polypoidal choroidal vasculopathy: 12-month outcomes in the Japanese cohort of EVEREST II study
Takahashi K, Ohji M, Terasaki H, Honda S, Margaron P, Guerin T, Yuzawa M
Clinical Ophthalmology 2018, 12:1789-1799
Published Date: 13 September 2018
Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions
Otsuji T, Sho K, Tsumura A, Koike N, Nishimura T, Takahashi K
Clinical Ophthalmology 2016, 10:431-436
Published Date: 11 March 2016
Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
Otsuji T, Nagai Y, Sho K, Tsumura A, Koike N, Tsuda M, Nishimura T, Takahashi K
Clinical Ophthalmology 2013, 7:1487-1490
Published Date: 22 July 2013
Choroidal melanoma with massive extraocular extensions through sclera
Kimura M, Ogata N, Shima C, Takahashi K
Clinical Ophthalmology 2012, 6:2081-2084
Published Date: 13 December 2012